167 related articles for article (PubMed ID: 31292398)
1. Hidden Charcot-Marie-Tooth 1A as Revealed by Peripheral Nerve Imaging.
Shibuya K; Yoshida T; Misawa S; Sekiguchi Y; Beppu M; Amino H; Suzuki YI; Suichi T; Tsuneyama A; Nakamura K; Kuwabara S
Intern Med; 2019 Nov; 58(21):3157-3161. PubMed ID: 31292398
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance neurography and diffusion tensor imaging of the peripheral nerves in patients with Charcot-Marie-Tooth Type 1A.
Vaeggemose M; Vaeth S; Pham M; Ringgaard S; Jensen UB; Tankisi H; Ejskjaer N; Heiland S; Andersen H
Muscle Nerve; 2017 Dec; 56(6):E78-E84. PubMed ID: 28500667
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
Grimm A; Vittore D; Schubert V; Lipski C; Heiling B; Décard BF; Axer H
Clin Neurophysiol; 2016 Jul; 127(7):2618-24. PubMed ID: 27291881
[TBL] [Abstract][Full Text] [Related]
4. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.
Saporta MA; Katona I; Lewis RA; Masse S; Shy ME; Li J
Brain; 2009 Dec; 132(Pt 12):3263-73. PubMed ID: 19923170
[TBL] [Abstract][Full Text] [Related]
5. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
[TBL] [Abstract][Full Text] [Related]
6. A family with IVIg-responsive Charcot-Marie-Tooth disease.
Miki Y; Tomiyama M; Haga R; Nishijima H; Suzuki C; Kurihara A; Sugimoto K; Hashiguchi A; Takashima H; Baba M
J Neurol; 2013 Apr; 260(4):1147-51. PubMed ID: 23232577
[TBL] [Abstract][Full Text] [Related]
7. Distinctive patterns of sonographic nerve enlargement in Charcot-Marie-Tooth type 1A and hereditary neuropathy with pressure palsies.
Goedee SH; Brekelmans GJ; van den Berg LH; Visser LH
Clin Neurophysiol; 2015 Jul; 126(7):1413-20. PubMed ID: 25454274
[TBL] [Abstract][Full Text] [Related]
8. Nerve ultrasound depicts peripheral nerve enlargement in patients with genetically distinct Charcot-Marie-Tooth disease.
Noto Y; Shiga K; Tsuji Y; Mizuta I; Higuchi Y; Hashiguchi A; Takashima H; Nakagawa M; Mizuno T
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):378-84. PubMed ID: 25091364
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of lower extremity ultrasonographic nerve enlargement for differentiating demyelinating Charcot-Marie-Tooth disease from chronic inflammatory demyelinating polyneuropathy.
Naito H; Sugimoto T; Hironaka A; Nakamori M; Yamazaki Y; Ochi K; Maruyama H
J Neurol Sci; 2024 May; 460():122995. PubMed ID: 38583391
[TBL] [Abstract][Full Text] [Related]
10. [Charcot-Marie-Tooth disease type 2 caused by homozygous MME gene mutation superimposed by chronic inflammatory demyelinating polyneuropathy].
Fujisawa M; Sano Y; Omoto M; Ogasawara JI; Koga M; Takashima H; Kanda T
Rinsho Shinkeigaku; 2017 Sep; 57(9):515-520. PubMed ID: 28855494
[TBL] [Abstract][Full Text] [Related]
11. Characterization of genetically defined types of Charcot-Marie-Tooth neuropathies by using magnetic resonance neurography.
Ellegala DB; Monteith SJ; Haynor D; Bird TD; Goodkin R; Kliot M
J Neurosurg; 2005 Feb; 102(2):242-5. PubMed ID: 15739551
[TBL] [Abstract][Full Text] [Related]
12. [Ultrasound diagnosis of Charcot-Marie-Tooth disease].
Noto Y
Brain Nerve; 2014 Mar; 66(3):237-46. PubMed ID: 24607948
[TBL] [Abstract][Full Text] [Related]
13. Nerve size correlates with clinical severity in Charcot-Marie-Tooth disease 1A.
Zanette G; Tamburin S; Taioli F; Lauriola MF; Badari A; Ferrarini M; Cavallaro T; Fabrizi GM
Muscle Nerve; 2019 Dec; 60(6):744-748. PubMed ID: 31469427
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the modified F-ratio for assessments of proximal conduction in chronic inflammatory demyelinating polyneuropathy superimposed on Charcot Marie-Tooth disease type 1A.
Kume K; Deguchi K; Ikeda K; Takata T; Kokudo Y; Kamada M; Tsukaguchi M; Touge T; Masaki T
J Neurol Sci; 2014 Aug; 343(1-2):237-9. PubMed ID: 24906712
[No Abstract] [Full Text] [Related]
15. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
[TBL] [Abstract][Full Text] [Related]
16. Peripheral nerve ultrasound in pediatric Charcot-Marie-Tooth disease type 1A.
Yiu EM; Brockley CR; Lee KJ; Carroll K; de Valle K; Kennedy R; Rao P; Delatycki MB; Ryan MM
Neurology; 2015 Feb; 84(6):569-74. PubMed ID: 25576636
[TBL] [Abstract][Full Text] [Related]
17. Nerve Ultrasound, Electrophysiological, and Clinical Changes in Treatment-Naive Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report.
Sato T; Terasawa Y; Higa H; Matsuno H; Arai A; Omoto S; Mitsumura H; Toyoda C; Koike H; Iguchi Y
J Clin Neurophysiol; 2019 Jan; 36(1):82-84. PubMed ID: 30260816
[TBL] [Abstract][Full Text] [Related]
18. Nerve ultrasound findings differentiate Charcot-Marie-Tooth disease (CMT) 1A from other demyelinating CMTs.
Zanette G; Fabrizi GM; Taioli F; Lauriola MF; Badari A; Ferrarini M; Cavallaro T; Tamburin S
Clin Neurophysiol; 2018 Nov; 129(11):2259-2267. PubMed ID: 30216910
[TBL] [Abstract][Full Text] [Related]
19. Compound muscle action potential duration ratio for differentiation between Charcot-Marie-Tooth disease and CIDP.
Kitaoji T; Noto YI; Kojima Y; Tsuji Y; Kitani-Morii F; Mizuno T; Nakagawa M
Clin Neurophysiol; 2023 Feb; 146():124-130. PubMed ID: 36608530
[TBL] [Abstract][Full Text] [Related]
20. [Ultrasonographic diagnosis of demyelinating neuropathy].
Sugimoto T; Ochi K; Matsumoto M
Rinsho Shinkeigaku; 2013; 23(11):1208-11. PubMed ID: 24291932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
